Asthma Allergy Immunology

17 Record Found

• A Rare Presentation of Coeliac Disease; Intractable Itching with Recurrent Heart Attack and Dermatitis Herpetiformis

  Sumeyra ALAN YALIM, Betül DUMANOĞLU, Merve POYRAZ, Gulistan ALPAGAT, Ayse BAÇÇIOĞLU, Ayse Fusun KALPAKLIOĞLU

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature

  Andac SALMAN, Meryem AKTAŞ

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Association of Cold Urticaria with Aquagenic Urticaria in an Adolescent Girl: A Case Report

  Mehmet KILIÇ, Erdal TAŞKIN, Mahir TAN, Alp GÖZÜTOK

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• SARS-CoV-2 in a Patient with Persistent Asthma Taking Omalizumab: The First Case in Turkey

  Emel ATAYIK, Gökhan AYTEKİN

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report

  Mehmet Erdem ÇAKMAK, Saltuk Buğra KAYA, Özge Can BOSTAN, Gülseren TUNCAY, Ebru DAMADOĞLU, Gül KARAKAYA, Ali Fuat KALYONCU

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Allergic Bronchopulmonary Aspergillosis: A Clinical Evaluation of 15 Patients and Successful Omalizumab Treatment of Five Patients

  Derya ÜNAL

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria

  Duru TABANLIOĞLU-ONAN, Ayşe ÖKTEM, Başak YALÇIN, Ferda ARTÜZ

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Allergic bronchopulmonary aspergillosis (ABPA)

  Dilara Fatma KOCACIK UYGUN, Serkan FİLİZ, Ayşen BİNGÖL

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study

  Sakine NAZİK BAHÇECİOĞLU, Murat TÜRK, Emel ATAYIK, Gülden PAÇACI ÇETİN, Bahar ARSLAN, İnci GÜLMEZ, İnsu YILMAZ

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Low Counts of Eosinophils After the 4th Dose of Mepolizumab May be an Independent Risk Factor for Sars-CoV-2 Transmission in Patients with Severe Asthma

  Emel ATAYIK, Gökhan AYTEKIN

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Efficacy of Omalizumab Treatment in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap (ACO)

  Dane EDIGER, Müge ERBAY, Ümmühan ŞEKER

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Hyperamylasemia During Omalizumab Therapy

  Esra KARABİBER, Özge ÖZTÜRK AKTAŞ, Ebru ÖZDEMIR, Ebru DAMADOĞLU, Ümit Murat ŞAHINER, Gül KARAKAYA, Ali Fuat KALYONCU

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Omalizumab in Practice: Ten-Year Experience of A Tertiary Referral Allergy Centre

  Nida ÖZTOP, Semra DEMIR, Şengül BEYAZ, Özdemir Can TÜZER, Bahauddin ÇOLAKOĞLU, Suna BÜYÜKÖZTÜRK, Aslı GELINCIK

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• The Frequency and Severity of COVID-19 in Patients Receiving Biological Agents and Risk Factors: Experience of an Allergy Clinic

  Sadan SOYYIGIT, Sengul BEYAZ, Zeynep CELEBI SOZENER

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Chronic Spontaneous Urticaria Patient Developing Idiopathic Anaphylaxis and Responding to Omalizumab Treatment: Case Report

  Oner OZDEMIR, Ummugulsum DIKICI, Busra Sultan KIBAR

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• Allergic Bronchopulmonary Aspergillosis Treated with Mepolizumab and Omalizumab: Switching Biological Agents

  Zeynep YEGIN KATRAN, Ismet BULUT

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite

• A Current Overview of Latex Allergy

  Feridun GURLEK

  Abstract Full Text:PDF Recommended articles Mail to Author How to Cite